GL Ventures leads $58.5m Series B round in China's GemPharmatech

GL Ventures leads $58.5m Series B round in China's GemPharmatech

14 September, 2020

biomedicine GemPharmatech gene-modified mouse models GL Ventures Morgan Stanley Sequoia Capital China

Printed by Unregistered user on Thu, 18 Dec 2025 00:40:51 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

Venture Capital

Chinese biotech startup IASO closes $60m Series B round led by GL Ventures

BGI Group's gene-sequencing equipment unit moves towards A-share IPO

Read more from Greater China

Venture Capital

HK stablecoin-based payment fintech RedotPay raises $107m

Inside China’s ‘Manhattan Project’ to master the tech to build AI chips